论文部分内容阅读
本文使用肝醒灵颗粒对109例慢活肝和94例肝硬化治疗观察,随机分为口服肝醒灵治疗组、静脉六合治疗组及对照组。治疗前后观察肝昏迷变化,测血BCAA/AAA、血氨、血BCAA/AAA比值动力学观察。结果前两组肝昏迷清醒率均为100%,而对照组为42.9%,x~2、p<0.01,前两组血氨全部降至正常,与对照组相比p<0.01,BCAA/AAA动力学口服组接近静脉组的高峰值,而且下降缓慢。
In this paper, Gan Xuan Ling particles 109 cases of slow-living liver and 94 cases of liver cirrhosis treatment were randomly divided into oral Gan Xun Ling treatment group, intravenous Liuhe treatment group and control group. The changes of hepatic coma were observed before and after treatment, and the kinetics of BCAA / AAA, blood ammonia and blood BCAA / AAA ratio were measured. Results The hepatic coma awakening rate was 100% in the first two groups, while the control group was 42.9%, x ~ 2, p <0.01. The first two groups of blood ammonia were all reduced to normal, p <0.01 compared with the control group, BCAA / AAA Kinetic oral group close to the peak value of the vein group, and decreased slowly.